货号:A271541
同义名:
3-甲氧基-4-羟基苯甲酸
/ 4-hydroxy-3-methoxybenzoic acid
Vanillic acid是一种香料,也是在由阿魏酸生产香兰素过程中使用的中间体。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | NF-κB ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammonium pyrrolidine-1-carbodithioate | ✔ | 98% | |||||||||||||||||
| QNZ |
++++
NF-κB, IC50: 11 nM |
99%+ | |||||||||||||||||
| Sodium 4-Aminosalicylate Dihydrate | ✔ | 98% | |||||||||||||||||
| Sodium Salicylate | ✔ | 95% | |||||||||||||||||
| Parthenolide | ✔ | p53 | 97% HPLC | ||||||||||||||||
| JSH-23 |
+
NF-κB, IC50: 7.1 μM |
98% | |||||||||||||||||
| Phenethyl caffeate | ✔ | 98% | |||||||||||||||||
| Andrographolide | ✔ | 98+% | |||||||||||||||||
| Curcumin | ✔ | Nrf2,HDAC | 98% | ||||||||||||||||
| SC75741 |
+++
NF-κB, EC50: 200 nM |
99%+ | |||||||||||||||||
| CBL0137 HCl |
++
NF-κB, EC50: 0.47 μM |
p53 | 99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| Concentration | Treated Time | Description | References | |
| Human colon cancer SW620 cells | 30 µM | 12 hours | Inhibited HIF-1α protein expression | Int J Mol Sci. 2019 Jan 22;20(3):465 |
| Human Umbilical Vein Endothelial Cells (HUVEC) | 30 µM | 12 hours | Inhibited tube formation | Int J Mol Sci. 2019 Jan 22;20(3):465 |
| Human lung carcinoma A549 cells | 30 µM | 12 hours | Inhibited HIF-1α protein expression | Int J Mol Sci. 2019 Jan 22;20(3):465 |
| Human hepatic cancer Hep3B cells | 30 µM | 12 hours | Inhibited HIF-1α protein expression | Int J Mol Sci. 2019 Jan 22;20(3):465 |
| Tomato seedlings | 50 µM | 2 days | VA pretreatment significantly enhanced the growth and biomass accumulation of tomato seedlings under drought stress, improved photosynthetic pigment content, water status, and proline content, while modulating the antioxidant defense system, reducing ROS generation and cellular membrane damage. | Plants (Basel). 2024 Nov 5;13(22):3114 |
| Bovine oocytes | 2 µM | 22–24 hours | Low VA concentration (2 µM) during IVM significantly enhanced the total number of cleaved embryos (84 ±1.58% vs. 75.8 ±2.20% for control; p < 0.05) without affecting the rates of 8–16 cell-stage embryos and day-8 blastocyst development. High VA concentrations (above 2 µM) significantly reduced all developmental parameters. | Nutrients. 2023 May 10;15(10):2257 |
| Human colon cancer HCT116 cells | 30 µM | 24 hours | Inhibited HIF-1α protein expression without affecting cell viability | Int J Mol Sci. 2019 Jan 22;20(3):465 |
| C2C12 myoblasts | 10 µM and 100 µM | 24 hours | Vanillic acid inhibited the expression of proteolytic markers (Fbxo32, Trim63, and Myostatin) and increased myofiber diameter in CT26 CM-treated C2C12 myoblasts. | Commun Biol. 2025 Apr 9;8(1):585 |
| B16BL6 melanoma cells | 0.01–1 µM | 24 hours | Evaluated the cytotoxicity of VA on B16BL6 melanoma cells, finding that 0.01–1 μM of VA does not affect cell viability. | Biomolecules. 2020 Jul 24;10(8):1098 |
| Fibroblast-like synoviocytes (FLSs) | 5 μg/ml | 24 hours | To evaluate the effect of vanillic acid on FLSs viability, results showed no significant effect on cell viability at 5 μg/ml. | Front Pharmacol. 2021 Feb 15;11:599022 |
| HT22 cells | 50, 100, 200 µM | 24 hours | To evaluate the protective effects of vanillic acid against Aβ1-42-induced cytotoxicity. Results showed that vanillic acid significantly increased HT22 cell viability and reduced reactive oxygen species (ROS) production. | Sci Rep. 2017 Jan 18;7:40753 |
| PC12 cells | 10-20 µM | 24 hours | To evaluate the protective effect of vanillic acid on corticosterone-induced PC12 cell injury. Results showed that vanillic acid significantly improved cell viability and reduced LDH release rate. | ACS Omega. 2024 Sep 23;9(39):40456-40467 |
| H9c2 cells | 50–200 µM | 3 hours | Vanillic acid attenuated H2O2-induced injury in H9c2 cells by regulating mitophagy via the PINK1/Parkin/Mfn2 signaling pathway, reducing the production of reactive oxygen species and malondialdehyde, increasing the levels of superoxide dismutase and glutathione, and improving mitochondrial membrane potential polarization and cellular calcium levels. | Front Pharmacol. 2022 Sep 7;13:976156 |
| RAW264.7 cells | 25, 50, 100 μg/ml | 4 hours | To investigate the effects of vanillic acid on LPS-induced inflammatory response in RAW264.7 cells. Results showed that vanillic acid significantly inhibited the expression of TNF-α, IL-6, IL-1β, MCP-1, and iNOS, and exerted anti-inflammatory effects by inhibiting the activation of NF-κB and MAPK signaling pathways. | Inflammopharmacology. 2025 Apr;33(4):1949-1963 |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | HCT116 xenografted tumor model | Oral | 10 mg/kg and 30 mg/kg | Three times a week for 50 days | Significantly inhibited tumor growth and reduced HIF-1α and VEGF protein expressions | Int J Mol Sci. 2019 Jan 22;20(3):465 |
| C57BL6/J mice | HFD-induced obese and B16BL6 melanoma-injected model | Oral gavage | 10 mg/kg/day | Every other day for two weeks | Evaluated the effect of VA on a comorbidity model of obesity and melanoma, finding that VA reduced body weight and white adipose tissue weight by increasing thermogenesis and AMPK activation in WATs, while also suppressing cancer growth. | Biomolecules. 2020 Jul 24;10(8):1098 |
| BALB/c mice | CT26 colon cancer-induced cachexia model | Oral | 100 mg/kg | Five times per week for three weeks | Vanillic acid improved body weight loss, muscle atrophy, and serum inflammatory cytokine levels in CT26-induced cachectic mice and enhanced mitochondrial function by regulating SIRT3 and MFN1. | Commun Biol. 2025 Apr 9;8(1):585 |
| Sprague-Dawley rats | Knee osteoarthritis model | Gastric intubation | 30 mg/kg | Once daily for 42 days | To investigate the effect of vanillic acid on pain-related behavior in knee osteoarthritis rats, results showed VA significantly alleviated pain-related behavior and downregulated the expression of pain mediators CGRP, NGF, and TrkA. | Front Pharmacol. 2021 Feb 15;11:599022 |
| C57BL/6N mice | Aβ1-42-induced Alzheimer's disease model | Intraperitoneal injection | 30 mg/kg | Once daily for 3 weeks | To evaluate the protective effects of vanillic acid against Aβ1-42-induced oxidative stress and cognitive impairment. Results showed that vanillic acid significantly reduced ROS levels, improved cognitive function, and reduced neuroinflammation and neurodegeneration. | Sci Rep. 2017 Jan 18;7:40753 |
| Mice | LPS-induced neurotoxicity model | Intraperitoneal injection | 30 mg/kg/day | Once daily for 14 days | Vanillic acid significantly attenuated LPS-induced neuroinflammation, amyloidogenesis, synaptic dysfunction, and memory impairment by inhibiting the LPS/RAGE-mediated JNK signaling pathway | Int J Mol Sci. 2020 Dec 31;22(1):361 |
| DBA/1 J mice | Collagen-induced arthritis model | Intraperitoneal injection | 5, 10, 20 mg/kg/d | Once daily for 14 days | To investigate the therapeutic effects of vanillic acid on collagen-induced arthritis in mice. Results showed that vanillic acid significantly improved the clinical symptoms and bone destruction of arthritis, reduced pathological damage to ankle synovial and spleen tissue, and inhibited polarization of macrophages to M1 in the synovial tissue. Additionally, vanillic acid inhibited the expression of TNF-α, IL-6, IL-1β, MCP-1, and iNOS in CIA mice and LPS-stimulated RAW264.7 cells, as well as the phosphorylation of p65, IκBα, ERK, JNK, and p38 MAPKs. | Inflammopharmacology. 2025 Apr;33(4):1949-1963 |
| Tomato (Solanum lycopersicum L. cv. BARI Tomato-16) | Hydroponically grown tomato seedlings | Hydroponic solution pretreatment | 50 µM | Pretreatment for 2 days followed by 4 days of drought stress | VA pretreatment significantly enhanced the growth and biomass accumulation of tomato seedlings under drought stress, improved photosynthetic pigment content, water status, and proline content, while modulating the antioxidant defense system, reducing ROS generation and cellular membrane damage. | Plants (Basel). 2024 Nov 5;13(22):3114 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.95mL 1.19mL 0.59mL |
29.74mL 5.95mL 2.97mL |
59.47mL 11.89mL 5.95mL |
|
| CAS号 | 121-34-6 |
| 分子式 | C8H8O4 |
| 分子量 | 168.15 |
| SMILES Code | C1=C(OC)C(=CC=C1C(O)=O)O |
| MDL No. | MFCD00002551 |
| 别名 | 3-甲氧基-4-羟基苯甲酸 ;4-hydroxy-3-methoxybenzoic acid |
| 运输 | 蓝冰 |
| InChI Key | WKOLLVMJNQIZCI-UHFFFAOYSA-N |
| Pubchem ID | 8468 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
| 溶解方案 |
DMSO: 105 mg/mL(624.45 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1